Conference abstract · 2 Nov 2017
Conference abstractPublished 17 Jul 2017
Emap-II-induced immune suppression in colorectal cancer
Minia University, Egypt; Indiana University School of Medicine, Indianapolis, Indiana
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Colorectal cancer (CRC) is being currently considered one of the most common and deadly malignancies in the world. Many CRC patients are likely to be immunosuppressive. Endothelial monocyte-activating polypeptide-II (EMAP-II) is a multifunctional cytokine with pro-inflammatory properties. It was demonstrated that EMAP-II induces lymphocytes apoptosis in CRC. The purpose of this study is to investigate the role of EMAP II in immune suppression in CRC. Methodology & Theoretical Orientation: The immunosuppressive effect of EMAP-II was verified by in vivo and in vitro experiments. The immunosuppressive mechanisms were analysed using flow cytometry, ELISA, immunohistochemistry and T-lymphocytes assays. Findings: EMAP-II expression in CRC was associated with suppression of T-cell activity and decreased infiltrating T-cells. EMAP-II blockade in mice bearing colorectal cancer reduced tumour burden and increased T-cell responses. In this study, we found that colorectal cancer-infiltrating tregs expressed increased levels of EMAP-II. Furthermore, EMAP-II levels correlated positively with serum IL-2 and TGF-Ã?² (p<0.001). Conclusion & Significance: This study has demonstrated the role of EMAP-II in immune suppression and the potential for immunotherapy via blocking EMAP-II in CRC.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 15 Oct 2013
Overcoming radiation-induced immune suppression by targeting the PD1/PDL1 axis
Short communication · 29 Feb 2024
Leveraging the Immune System for Metastasis Suppression: A Promising Frontier in Cancer Therapy.
Editorial · 15 Feb 2021
Targeting Immune-Mediated Suppressive Mechanisms as a Novel Cancer Immunotherapy Strategy
Review article · 2021
Targeting Immune-Mediated Suppressive Mechanisms as a Cancer Immunotherapy Strategy
More from this journal
The newest in Immunotherapy: Open Access.
Perspective · 19 Mar 2025
Understanding the Immune Response to Checkpoint Inhibitors in Immunotherapy
Perspective · 19 Mar 2025
Advancing Immunotherapy: Future Directions in the Fight against Renal Cell Carcinoma
Short communication · 19 Mar 2025
Emerging Therapies: The Latest Developments in Autoimmune Disease Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalImmunotherapy: Open Access
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Manal Mohamed Saber”
- BylineArticles whose byline prints “Matthias Clauss”

